Growth hormone-releasing hormone stimulates the secretion of interleukin 17 from human peripheral blood mononuclear cells in vitro

Neuroendocrinology Letters

Volumn 31, Issue 6, 2010, Pages 852-856

  Stepien, Tomasz ^a   Lawnicka, Hanna ^b   Komorowski, Jan ^b   Stepien, Henryk ^b   Siejka, Agnieszka ^b  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

GHRH; Interleukin 17; Neuroimmunomodulation

Indexed keywords

GROWTH HORMONE RELEASING FACTOR; INTERLEUKIN 17;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; NEUROMODULATION; PERIPHERAL BLOOD MONONUCLEAR CELL;

EID: 79751498142     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Barabutis N, Schally AV (2008). Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines. Br J Cancer 98: 1790-1796. (Pubitemid 351748851)
2. Barabutis N, Siejka A, Schally A, Block N, Cai R, Varga J (2010). Activation of mitogen activated protein kinases by a splice variant of growth hormone releasing hormone receptor. J Mol Endocrinol. 44: 127-134.
3. Besedovsky HO, del Rey A (1996). Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17: 64-102.
4. Blazar BR, Brennan CA, Broxmeyer HE, Shultz LD, Vallera DA (1995). Transgenic mice expressing either bovine growth hormone (bGH) or human GH releasing hormone (hGRH) have increased splenic progenitor cell colony formation and DNA synthesis in vitro and in vivo. Exp Hematol 23: 1397-1406. (Pubitemid 26043018)
5. Botteri FM, van der Putten H, Wong DF, Sauvage CA, Evans RM (1987). Unexpected thymic hyperplasia in transgenic mice harboring a neuronal promoter fused with simian virus 40 large T antigen. Mol Cell Biol 7: 3178-3184.
6. Charles KA, Kulbe H, Soper R, Escorcio-Correia M, Lawrence T, Schultheis A, Chakravarty P, Thompson RG, Kollias G, Smyth JF, Balkwill FR, Hagemann T (2009). The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest 119: 3011-3023.
7. Gaffen SL (2009). Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9: 556-567.
8. Guarcello V, Weigent DA, Blalock JE (1991). Growth hormone releasing hormone receptors on thymocytes and splenocytes from rats. Cell Immunol 136: 291-302.
9. Keller G, Schally AV, Groot K, Toller GL, Havt A, Koster F, Armatis P, Halmos G, Zarandi M, Varga JL, Engel JB (2005). Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone. Proc Natl Acad Sci U S A 102: 10628-10633. (Pubitemid 41061605)
10. Khorram O, Garthwaite M, Golos T (2001). The influence of aging and sex hormones on expression of growth hormone-releasing hormone in the human immune system. J Clin Endocrinol Metab 86: 3157-3161. (Pubitemid 32673480)
11. Khorram O, Yeung M, Vu L, Yen SS (1997). Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women. J Clin Endocrinol Metab 82: 3590-3596. (Pubitemid 27509342)
12. Komorowski J, Jankiewicz-Wika J, Stepien H (2000). Somatostatin (SOM) and octreotide (OCT) inhibit the secretion of interleukin-8 (IL-8) from human peripheral blood mononuclear cells (PBMC) in vitro. Horm Metab Res 32: 337-338.
13. Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, Harris T, Drake C, Pardoll D, Yu H (2009). Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 15: 114-123.
14. Kortylewski M, Yu H (2008). Role of Stat3 in suppressing antitumor immunity. Curr Opin Immunol 20: 228-233.
15. Mayo KE, Miller T, DeAlmeida V, Godfrey P, Zheng J, Cunha SR (2000). Regulation of the pituitary somatotroph cell by GHRH and its receptor. Recent Prog Horm Res 55: 237-266; discussion 266-237.
16. Mumm JB, Oft M (2008). Cytokine-based transformation of immune surveillance into tumor-promoting inflammation. Oncogene 27: 5913-5919.
17. Murugaiyan G, Saha B (2009). Protumor vs antitumor functions of IL-17. J Immunol 183: 4169-4175.
18. Pombo CM, Zalvide J, Gaylinn BD, Dieguez C (2000). Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. Endocrinology 141: 2113-2119. (Pubitemid 32274364)
19. Sacewicz M, Lawnicka H, Siejka A, Stepien T, Krupinski R, Komorowski J, Stepien H (2008). Inhibition of proliferation, VEGF secretion of human neuroendocrine tumor cell line NCl-H727 by an antagonist of growth hormone-releasing hormone (GH-RH) in vitro. Cancer Lett 268: 120-128.
20. Schally AV, Varga JL, Engel JB (2008). Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer. Nat Clin Pract Endocrinol Metab 4: 33-43. (Pubitemid 350291102)
21. Siejka A, Lawnicka H, Komorowski J, Schally AV, Stepien T, Krupinski R, Stepien H (2003). GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells. Life Sci 72: 2473-2479.
22. Siejka A, Lawnicka H, Komorowski J, Stepien T, Krupinski R, Stepien H (2004). Effect of growth hormone-releasing hormone (GHRH) and GHRH antagonist (MZ-4-71) on interferon-gamma secretion from human peripheral blood mononuclear cells in vitro. Neuropeptides 38: 35-39. (Pubitemid 38372963)
23. Siejka A, Schally AV, Barabutis N (2010). Activation of Janus kinase/signal transductor and activator of transcription 3 pathway by growth hormone-releasing hormone. Cell Mol Life Sci. 67: 959-954.
24. Siejka A, Stepien T, Lawnicka H, Krupinski R, Komorowski J, Stepien H (2005). [Evaluation of the effect of GHRH(1-44)NH2 on the secretion of interleukin-2 (IL-2) and soluble IL-2 receptor alpha (slL-2Ralpha) from human peripheral blood mononuclear cells in vitro]. Endokrynol Pol 56: 773-778.
25. Sirianni MC, Annibale B, Tagliaferri F, Fais S, De Luca S, Pallone F, Delle Fave G, Aiuti F (1992). Modulation of human natural killer activity by vasoactive intestinal peptide (VIP) family. VIP, glucagon and GHRF specifically inhibit NK activity. Regul Pept 38: 79-87.
26. Siriwardana G, Bradford A, Coy D, Zeitler P (2006). Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol Endocrinol 20: 2010-2019. (Pubitemid 44286701)
27. Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H (2009). IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 206: 1457-1464.
28. Weigent DA, Blalock JE (1990). Immunoreactive growth hormone-releasing hormone in rat leukocytes. J Neuroimmunol 29: 1-13. (Pubitemid 20283777)
29. Weigent DA, Riley JE, Galin FS, LeBoeuf RD, Blalock JE (1991). Detection of growth hormone and growth hormone-releasing hormone-related messenger RNA in rat leukocytes by the polymerase chain reaction. Proc Soc Exp Biol Med 198: 643-648.
30. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL (2009). A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15: 1016-1022.
31. Zeitler P, Siriwardana G (2000). Stimulation of mitogen-activated protein kinase pathway in rat somatotrophs by growth hormone-releasing hormone. Endocrine 12: 257-264. (Pubitemid 30432242)
32. Zelazowski P, Dohler KD, Stepien H, Pawlikowski M (1989). Effect of growth hormone-releasing hormone on human peripheral blood leukocyte Chemotaxis and migration in normal subjects. Neuroendocrinology 50: 236-239. (Pubitemid 19179852)